BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 24301304)

  • 1. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
    Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB
    Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.
    Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y
    Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
    Han PA; Kim HS; Cho S; Fazeli R; Najafian A; Khawaja H; McAlexander M; Dy B; Sorensen M; Aronova A; Sebo TJ; Giordano TJ; Fahey TJ; Thompson GB; Gauger PG; Somervell H; Bishop JA; Eshleman JR; Schneider EB; Witwer KW; Umbricht CB; Zeiger MA
    Thyroid; 2016 Apr; 26(4):532-42. PubMed ID: 26950846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer.
    Kondrotienė A; Daukša A; Pamedytytė D; Kazokaitė M; Žvirblienė A; Daukšienė D; Simanavičienė V; Klimaitė R; Golubickaitė I; Stakaitis R; Šarauskas V; Verkauskienė R; Žilaitienė B
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 6. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
    Yip L; Kelly L; Shuai Y; Armstrong MJ; Nikiforov YE; Carty SE; Nikiforova MN
    Ann Surg Oncol; 2011 Jul; 18(7):2035-41. PubMed ID: 21537871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.
    Sondermann A; Andreghetto FM; Moulatlet AC; da Silva Victor E; de Castro MG; Nunes FD; Brandão LG; Severino P
    Clin Exp Metastasis; 2015 Aug; 32(6):521-30. PubMed ID: 26007293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.
    Chou CK; Liu RT; Kang HY
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222.
    Lee JC; Zhao JT; Gundara J; Serpell J; Bach LA; Sidhu S
    J Surg Res; 2015 Jun; 196(1):39-48. PubMed ID: 25819770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer.
    Dai L; Wang Y; Chen L; Zheng J; Li J; Wu X
    World J Surg Oncol; 2017 Jan; 15(1):11. PubMed ID: 28061868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC.
    Hu J; Li C; Liu C; Zhao S; Wang Y; Fu Z
    Cancer Biomark; 2017; 18(1):87-94. PubMed ID: 28085013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses.
    Graham ME; Hart RD; Douglas S; Makki FM; Pinto D; Butler AL; Bullock M; Rigby MH; Trites JR; Taylor SM; Singh R
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):33. PubMed ID: 26341226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.
    Zhang Y; Xu D; Pan J; Yang Z; Chen M; Han J; Zhang S; Sun L; Qiao H
    Oncol Lett; 2017 Jun; 13(6):4252-4266. PubMed ID: 28599426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression levels of plasma-derived miR-146b and miR-155 in papillary thyroid cancer.
    Lee YS; Lim YS; Lee JC; Wang SG; Park HY; Kim SY; Lee BJ
    Oral Oncol; 2015 Jan; 51(1):77-83. PubMed ID: 25456009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
    Qiu Z; Li H; Wang J; Sun C
    Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M; Wu W; Gao M; Fei Z
    Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
    BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.